The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis
Abstract
Objective To systematically assess the effectiveness of systemic cyclosporin in patients with severe atopic eczema. Study design Systematic review and meta‐analysis of controlled and uncontrolled trials. Electronic (MEDLINE, Cochrane databases) and hand search of published work. Independent standardized assessment of eligibility and data abstraction by two reviewers. Methods For the qualitative review data on study design, study population, methodology, results, tolerability and methodological quality was independently extracted by two reviewers. Qualitatively homogeneous studies were pooled using a random‐effects model. The mean relative change in objective disease severity was chosen as the main outcome measure for the quantitative analysis. Publication bias was explored by regressing treatment effect on sample size. Sensitivity analysis included meta‐regression of study‐specific covariates (inclusion of children, study type, concomitant topical therapy, study quality). Results Fifteen studies including 602 patients met the eligibility criteria. In all studies analysed, cyclosporin consistently decreased the severity of atopic eczema. Twelve studies appeared homogeneous enough to be pooled. After 2 weeks of treatment we found a dose‐related response with a pooled mean decrease in disease severity of 22% (95%‐CI 8–36%) under low‐dose cyclosporin ( 3 mg/kg) and 40% (95%‐CI 29–51%) at dosages 4 mg/kg. After 6–8 weeks the relative effectiveness was 55% (95%‐CI 48–62%). Conclusions Due to evidence of publication bias the quantitative results need to be interpreted with caution. Effectiveness of cyclosporin is similar in adults and children, but tolerability might be better in children. As data to adequately evaluate the long‐term effectiveness and safety of cyclosporin in patients with atopic eczema are unavailable, long‐term registries are encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644
Biological effects of cyclosporin A: A new antilymphocytic agent
Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H. (1976) · Agents and Actions · doi:10.1007/bf01973261 · Cited by 1,509
A comparison of methods to detect publication bias in meta‐analysis
Macaskill, P., Walter, S. D., & Irwig, L. (2001) · Statistics in Medicine · doi:10.1002/sim.698 · Cited by 1,286
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
LEWIS-JONES, M. S., & FINLAY, A. Y. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16953.x · Cited by 1,051
Williams, H., Robertson, C., Stewart, A., Aït-Khaled, N., Anabwani, G., Anderson, R., Asher, I., Beasley, R., Björkstén, B., Burr, M., et al. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70536-1 · Cited by 998
Williams, H. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042803 · Cited by 523
The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society
Carroll, C. L., Balkrishnan, R., Feldman, S. R., Fleischer, A. B., & Manuel, J. C. (2005) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2005.22303.x · Cited by 489
10 Years Experience of the Dermatology Life Quality Index (DLQI)
Lewis, V., & Finlay, A. Y. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09113.x · Cited by 479
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.2165/00003495-199345060-00007 · Cited by 468
Faulds, D., Goa, K. L., & Benfield, P. (1993) · Drugs · doi:10.1007/bf03259110 · Cited by 436
Sowden, J. M., Allen, B. R., Berth-Jones, J., Graham-Brown, R. A. C., Motley, R. J., Finlay, A. Y., Salek, M., Marks, R., Ross, J. S., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Guidelines of care for atopic dermatitis
Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.08.003 · Cited by 387
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction
Liu, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90048-p · Cited by 383
Effects of Atopic Dermatitis on Young American Children and Their Families
Chamlin, S. L., Frieden, I. J., Williams, M. L., & Chren, M.-M. (2004) · Pediatrics · doi:10.1542/peds.2004-0374 · Cited by 316
Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting
WILLIAMS, H. C., BURNEY, P. G. J., PEMBROKE, A. C., HAY, R. J., & PARTY, O. B. O. T. U. K. D. C. F. A. D. W. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-925.x · Cited by 305
Harper, J. I., Ahmed, I., Barclay, G., Lacour, M., Hoeger, P., Cork, M. J., Finlay, A. Y., Wilson, N. J. E., Graham-Brown, R. A. C., Sowden, J. M., et al. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03241.x · Cited by 281
Marcil, I., & Stern, R. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06179-7 · Cited by 258
Ellis, C., Luger, T., Faculty:, T. I. I., Abeck, D., Allen, R., Graham-Brown, R. A. C., de Prost, Y., Eichenfield, L. F., Ferrandiz, C., Giannetti, A., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.148.s63.1.x · Cited by 217
Outcome Measures of Disease Severity in Atopic Eczema
Charman, C., & Williams, H. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.6.763 · Cited by 203
Cyclosporine in severe childhood atopic dermatitis: A multicenter study
Berth-Jones, J., Finlay, A. Y., Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S., Cork, M. J., Bleehen, S. S., Salek, M. S., Allen, B. R., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90281-9 · Cited by 195
Prognosis of Atopic Dermatitis: A Prospective Study in Early Adulthood
Lammintausta, K. H., Kalimo, K., Raitala, R., & Forsten, Y. (1991) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1991.tb02641.x · Cited by 193
BERTH-JONES, J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb00706.x · Cited by 191
Emerson, Williams, & Allen (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02316.x · Cited by 188
Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study
JOOST, T., HEULE, F., KORSTANJE, M., BROEK, M. J. T. B., STENVELD, H. J., & VLOTEN, W. A. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb13111.x · Cited by 183
Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
BERTH-JONES, J., GRAHAM-BROWN, R. A. C., MARKS, R., CAMP, R. D. R., ENGLISH, J. S. C., FREEMAN, K., HOLDEN, C. A., ROGERS, S. C. F., OLIWIECKI, S., FRIEDMANN, P. S., et al. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.d01-1146.x · Cited by 175
Prognosis of atopic dermatitis. A prospective study in early adulthood.
Lammintausta, K. H., Kalimo, K., Raitala, R., et al. (1991) · PubMed · Cited by 169
Fivenson, D. P., Arnold, R. J. G., Kaniecki, D. J., Cohen, J. L., Frech, F., & Finlay, A. Y. (2002) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2002.8.5.333 · Cited by 159
Dickel, H., Bruckner, T. M., Diepgen, T. L., & Schmidt, A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12323.x · Cited by 145
Scoring atopic dermatitis: the simpler the better?
Costa, C., Rilliet, A., Nicolet, M., & Saurat, J. ‐. (1989) · PubMed · Cited by 140
Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry‐over
Curtin, F., Elbourne, D. R., & Altman, D. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1207 · Cited by 123
Cost of Illness of Atopic Dermatitis in Children: A Societal Perspective
Kemp, A. S. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321020-00003 · Cited by 121
Quality of life in atopic dermatitis
Finlay, A. Y. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117010 · Cited by 118
Long term follow-up in atopic dermatitis.
Rystedt, I. (1985) · PubMed · doi:10.2340/00015555114117120 · Cited by 100
Czech, W., Bräutigam, M., Weidinger, G., & Schöpf, E. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103815 · Cited by 96
Novel cycle changes in scalp hair are caused by etretinate therapy
Berth‐Jones, J., & Hutchinson, P. E. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb08669.x · Cited by 82
Bunikowski, R., Staab, D., Kussebi, F., et al. (2001) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2001.012004216.x · Cited by 76
Pacor, M. L., Lorenzo, G. D., Martinelli, N., Mansueto, P., Rini, G. B., & Corrocher, R. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1907.x · Cited by 70
Comparison of Two Formulations of Cyclosporin A in the Treatment of Severe Atopic Dermatitis
Zurbriggen, B., Wüthrich, B., Cachelin, A. B., Wili, P. B., & Kägi, M. K. (1999) · Dermatology · doi:10.1159/000018065 · Cited by 47
Giving "Scale" New Meaning in Dermatology: Measurement Matters
Chren, M. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.6.788 · Cited by 35
Cited by
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0001-z · Cited by 1,549
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,277
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Guidelines of care for the management of atopic dermatitis
Sidbury, R., Davis, D. M., Cohen, D. E., Cordoro, K. M., Berger, T. G., Bergman, J. N., Chamlin, S. L., Cooper, K. D., Feldman, S. R., Hanifin, J. M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.030 · Cited by 885
Metadata
- Authors
- Schmitt, J., Schmitt, N., & Meurer, M.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2007-03-22
- Volume
- 21
- Issue
- 5
- Pages
- 606-619
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2147391287
- Cited by
- 265
- References
- 44
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.